Overview
- 5 inspections across 5 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2012-01-25.
At a glance
Inspections
5
Sites
5
Observations
0
Career since
Aug 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 25 Jan 2012 | On file | |
| Cangene BioPharma, LLC. | 27 May 2011 | On file | |
| Merck Sharp & Dohme LLC | 14 May 2010 | On file | |
| Sanofi Winthrop Industrie | 4 Feb 2009 | On file | |
| Immucor, Inc. | 15 Aug 2008 | On file |
Sites inspected
Merck Sharp & Dohme LLCElkton, United States1 insp.
Cangene BioPharma, LLC.Rockville, United States1 insp.
Merck Sharp & Dohme LLCDurham, United States1 insp.
Sanofi Winthrop IndustrieMarcy-L'Etoile, France1 insp.
Immucor, Inc.Peachtree Corners, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Marion Michaelis2 shared
Anthony F Lorenzo1 shared
Rachel C Harrington1 shared
Ellen Huang1 shared
Joseph D Doleski1 shared
Destry M Sillivan1 shared
Randa Melhem1 shared
Sean R Byrd1 shared
Susan S Yu1 shared
Full investigator report
Get the verbatim findings behind Nawab A Siddiqui's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site